MR13A9: Clinical Trials

2 trials of MR13A9, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow MR13A9: new trials by email Literature Review of MR13A9 trials Research Report on MR13A9

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
MR13A9, Placebo - Uremic Pruritus
Phase 3CompletedKissei Pharmaceutical Co., Ltd.1782021-01-162025-09-10
A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
MR13A9, Placebo - Uremic Pruritus
Phase 2CompletedKissei Pharmaceutical Co., Ltd.2472019-02-012025-12-05

Sponsors

Kissei Pharmaceutical Co., Ltd. (2)

Countries

Japan (2)

Top investigators

Naomi Koshihara (1)  ·  Yoshitaka Shimizu (1)

Results publications

PMID 35511180, PMID 38320524